Performance analysis of Channel Therapeutics (PTHS)
Annual Return
Since Feb 16, 2024, PTHS has had an average annual return of -23.59%, underperforming the benchmark SPY, which returned +21.08% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -16.51% | +383.75% | -86.65% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -22.51% | +9.75% | -20.30% | +18.99% | +5.89% | -2.23% | -16.51% | ||||||
| 2025 | +265.17% | -12.39% | -30.74% | -19.71% | -18.82% | +36.15% | +67.85% | +11.82% | +18.39% | +17.86% | -13.93% | +9.14% | +383.75% |
| 2024 | -21.46% | -30.51% | -31.68% | -25.13% | -1.50% | -18.95% | -13.06% | -23.68% | -12.64% | -1.47% | +4.87% | -86.65% |
Drawdown analysis of Channel Therapeutics (PTHS)
The maximum drawdown for the PTHS was -88.73%, occurring on Nov 19, 2024. This drawdown has not yet recovered.
The current PTHS drawdown is -46.08%.
Since Feb 16, 2024 PTHS has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -88.73% | Feb 16, 2024 | 191 | Nov 19, 2024 | Ongoing | Ongoing | Ongoing |